Capri is projecting a rebound in adjusted revenue to $4.4 billion in fiscal 2027, above current analyst estimates for $4.31 billion in net revenue, and a jump to $4.7 billion in fiscal 2028. Shares ...
Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) will be announcing earnings results tomorrow morning. Here ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback